National manufacturer of
immunobiological products in Russia
Apr 20, 2024, 13:35 (Moscow)
+7 (495) 790-77-73
En
National manufacturer of
immunobiological products in Russia

Facts and figures

manufacturing sites
9
manufacturing sites
specialists
5500
specialists
the Company provides for country's needs in vaccines and toxoids
40 %
the Company provides for country's needs in vaccines and toxoids
the exclusive producer of therapeutic bacteriophages
1
the exclusive producer of therapeutic bacteriophages
mln roubles – investments for development and production of the products in 2020
250
mln roubles – investments for development and production of the products in 2020
million packages of medicines per year – the production capacity of Microgen
18
million packages of medicines per year – the production capacity of Microgen
years of application of the first botulinum toxin type A – hemagglutinin complex
10 +
years of application of the first botulinum toxin type A – hemagglutinin complex
Subscribe to news
News
Nacimbio brings to market new Hepatitis B drug
25.10.2023
Nacimbio brings to market new Hepatitis B drug
New productions to be created at Microgen
04.06.2021
New productions to be created at Microgen
Relatox® entered the Uzbek market
01.06.2021
Relatox® entered the Uzbek market
Microgen increases the export of pharmaceuticals to Uzbekistan
20.05.2021
Microgen increases the export of pharmaceuticals to Uzbekistan
NPO Microgen and National Association of the Specialists in Infections Control agreed to pool efforts in vaccination popularization area
26.04.2021
NPO Microgen and National Association of the Specialists in Infections Control agreed to pool efforts in vaccination popularization area
Perm subsidiary of NPO Microgen to expand the production of vaccines and blood products
15.04.2021
Perm subsidiary of NPO Microgen to expand the production of vaccines and blood products
Microgen obtained registration for the new vaccine
09.02.2021
Microgen obtained registration for the new vaccine
Microgen launched a mobile application about vaccines
23.12.2020
Microgen launched a mobile application about vaccines
Relatox won the prestigious Beauty Award ′′Crystal Lotus”
07.12.2020
Relatox won the prestigious Beauty Award ′′Crystal Lotus”
Evgeny Stavnichy was appointed Director of NPO Microgen Ufa subsidiary.
02.12.2020
Evgeny Stavnichy was appointed Director of NPO Microgen Ufa subsidiary.
Microgen to start the production of new allergy drugs
06.08.2020
Microgen to start the production of new allergy drugs
Microgen started shipping its “three in one” combined vaccine against measles, rubella and mumps
20.07.2020
Microgen started shipping its “three in one” combined vaccine against measles, rubella and mumps
Perm subsidiary of NPO Microgen finished modernization of vaccine production department
28.05.2020
Perm subsidiary of NPO Microgen finished modernization of vaccine production department
Bacteriophage products were included into the European Position Paper on Rhinosinusitis and Nasal Polyps treatment
25.03.2020
Bacteriophage products were included into the European Position Paper on Rhinosinusitis and Nasal Polyps treatment
Bacteriophage products have been included into clinical recommendations for urology
27.02.2020
Bacteriophage products have been included into clinical recommendations for urology
Microgen opened Biological Resource Center for bacteriophages study
06.02.2020
Microgen opened Biological Resource Center for bacteriophages study
Relatox in dentistry: options of use
29.01.2020
Relatox in dentistry: options of use
NPO Microgen won an award for new vaccine creation
02.12.2019
NPO Microgen won an award for new vaccine creation
New vaccine will protect from three infections by one injection
18.11.2019
New vaccine will protect from three infections by one injection
Relatox® will extend the age of application in children with infantile cerebral paralysis (ICP)
24.10.2019
Relatox® will extend the age of application in children with infantile cerebral paralysis (ICP)
All news

Products

We produce more than 250 medical products and we are
the biggest manufacturer of the immunobiological products in Russia.
Vaccines
Allergens
Anatoxins, toxins
Bacteriophages
Immunomodulators, interferons
Blood products
Sera
Culture media
Medical devices for diagnostics in vitro
Other medicines
Moscow Subdivision for Manufacture of Bacterial Products
15, 1-Dubrovskaya St., Moscow, 115088
+7 (495) 674-55-80
 Moscow
Immunopreparat
105 Novorossiyskaya St., Ufa, 450014
+7 (347) 229-92-01
 Ufa
Nizhny Novgorod Enterprise for Manufacture of Bacterial Products ‘ImBio’
44 Gruzinskaya str., Nizhny Novgorod, 603950, Nizhny Novgorod.
+7 (831) 296-91-16
 Nizhny Novgorod
Perm SPA ‘Biomed’
177 Bratskaya str., Perm, 614089.
+7 (342) 281-94-96
 Perm
Allergen
20 Biologicheskaya str., Stavropol, 355019
+7 (8652) 24-40-84
 Stavropol
SPA Nutrient Media
89, Dekorativnaya str., building 1, 367915, Republic of Dagestan, Novy Kyakhulai settlement
+7 (8722) 55-82-32
 Makhachkala
Omsk Enterprise for Manufacture of Bacterial Products
7 Mira Ave., Omsk, 644080
8 (3812) 65-14-63
 Omsk
SPA Virion
8 Ivanovskogo str., Tomsk, 634040
+7 (3822) 905-808
 Tomsk
Irkutsk Enterprise for Manufacture of Bacterial Products
664009, Irkutsk, 3rd Letchikov str., 1 "A"
+7 (3952) 27-12-31
 Irkutsk
Subsidiaries
9 manufacturing sites
Moscow Subdivision for Manufacture of Bacterial Products
Vaccine production
Immunopreparat
Production of bacteriophages, botulinum toxin type A, vaccines and anatoxins, immunoglobulins, albumin, heterologous sera, diagnostic preparations and finished pharmaceuticals.
Nizhny Novgorod Enterprise for Manufacture of Bacterial Products ‘ImBio’
Production of bacteriophages, immunoglobulins, probiotics, blood products, heterologous sera and diagnostic preparations.
Perm SPA ‘Biomed’
Production of bacteriophages, vaccines and anatoxins, immunoglobulins, probiotics, albumin, heterologous sera, diagnostic preparations and finished pharmaceuticals products.
Allergen
Production of allergens and allergoids, vaccines, probiotics, immunopherment test systems, heterological serums, blood products and diagnostic drugs.
SPA Nutrient Media
Production of nutrient media and finished medicines.
Omsk Enterprise for Manufacture of Bacterial Products
Production of allergens, vaccines and diagnostic drugs.
SPA Virion
Production of vaccines, probiotics, immunoglobulins, enzyme immunoassay systems, blood products and diagnostic drugs.
Irkutsk Enterprise for Manufacture of Bacterial Products
The company's portfolio includes the influenza vaccine allantois live Ultravak®.